Pharmacokinetic interaction between multiple-dose venlafaxine and single-dose lithium. (Record no. 8846559)

MARC details
000 -LEADER
fixed length control field 01455 a2200409 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513102102.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199612s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0091-2700
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1002/j.1552-4604.1996.tb04183.x
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Troy, S M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19961211
245 00 - TITLE STATEMENT
Title Pharmacokinetic interaction between multiple-dose venlafaxine and single-dose lithium.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of clinical pharmacology
Date of publication, distribution, etc. Feb 1996
300 ## - PHYSICAL DESCRIPTION
Extent 175-81 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Comparative Study; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Administration, Oral
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antidepressive Agents, Second-Generation
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclohexanols
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Desvenlafaxine Succinate
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Administration Schedule
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Interactions
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lithium
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Selective Serotonin Reuptake Inhibitors
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Venlafaxine Hydrochloride
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Parker, V D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hicks, D R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Boudino, F D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chiang, S T
773 0# - HOST ITEM ENTRY
Title Journal of clinical pharmacology
Related parts vol. 36
-- no. 2
-- p. 175-81
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1002/j.1552-4604.1996.tb04183.x">https://doi.org/10.1002/j.1552-4604.1996.tb04183.x</a>
Public note Available from publisher's website

No items available.